What Is IGF-1? The Longevity Biomarker Nobody Tests

Photo by National Cancer Institute on Unsplash

By The Longevity Dose Editorial Team · Evidence-reviewed · Last updated August 2026

Insulin-like growth factor 1 (IGF-1) is a hormone produced mainly by the liver in response to growth hormone signaling, and the relationship between insulin-like growth factor 1 and aging sits at one of the most contested intersections in all of longevity science. Too little IGF-1 accelerates muscle loss, slows tissue repair, and impairs brain function. Too much may fuel cancer growth and shorten lifespan. Finding the right balance is less about chasing a number and more about understanding what drives it, and whether your current level is quietly working against you. Most standard blood panels skip it entirely. That’s a mistake worth correcting.

Why Insulin-Like Growth Factor 1 and Aging Are Inseparable

IGF-1 levels peak in your late teens and drop steadily from your 30s onward. By age 60, circulating IGF-1 has fallen substantially from its late-adolescent peak, a decline steep enough to track closely with loss of lean mass, slower tissue repair, and reduced cognitive speed. This decline, sometimes called the “somatopause,” tracks closely with some of the most visible signs of aging: loss of lean muscle mass, slower wound healing, thinner skin, and declining cognitive speed.

But the story isn’t simply “more is better.” Evidence shows that chronically elevated IGF-1, which can occur with obesity, excess dietary protein from certain sources, or exogenous growth hormone use, is associated with higher rates of colorectal, breast, and prostate cancers. The hormone is, in a real sense, a growth signal. And growth signals don’t discriminate between healthy cells and abnormal ones.

This tension sits at the heart of why IGF-1 is so important to understand. It’s one of the few biomarkers where both extremes are clearly dangerous. If you’re worried about sarcopenia warning signs at 40, low IGF-1 is almost certainly part of the picture. If you’re tempted by growth hormone therapy to reverse aging, the IGF-1 side effects deserve serious attention.

The Science Behind IGF-1: How It Actually Works

Your pituitary gland releases growth hormone (GH) in pulses, mostly during deep sleep. The liver picks up that GH signal and converts it into IGF-1, which then circulates through the bloodstream and binds to receptors on muscle, bone, nerve, and organ cells.

At the cellular level, IGF-1 activates the PI3K/Akt/mTOR pathway. That’s the “build and grow” signaling cascade. When it fires, cells increase protein synthesis, reduce apoptosis (programmed cell death), and ramp up glucose uptake. These are good things in the right context, especially after exercise or injury. But chronic overactivation of mTOR by high IGF-1 suppresses autophagy, which is the cellular cleanup process that clears out damaged proteins and dysfunctional organelles. You can read more about why autophagy matters in our deep dive on cellular self-cleaning.

IGF-1 also plays a direct neuroprotective role. A 2026 review in Metabolic Brain Disease (PMID: 41779215) found that IGF-1 naturally declines with age and that this age-related reduction is associated with the degeneration of dopaminergic neurons in Parkinson’s disease. IGF-1 appears to protect these neurons through anti-inflammatory and anti-apoptotic mechanisms. The review is observational and not a basis for treatment, but it reinforces that low IGF-1 isn’t neutral for the brain.

The Mitochondria Complication

Here’s where the science gets genuinely interesting. For decades, researchers studying model organisms found that reducing IGF-1 signaling extended lifespan consistently. Worm, fly, mouse data all pointed the same direction. But a 2026 study in Science Advances (PMID: 41931604) complicated that picture considerably.

Researchers found that the lifespan benefits of reduced IGF-1 signaling disappear entirely in mice with unstable mitochondrial genomes. The longevity pathways that IGF-1 suppression normally activates were blocked or blunted when mitochondrial function was already compromised. In other words, the longevity benefit of lower IGF-1 may depend on your mitochondria being in good shape first. That’s a critical nuance, and one that nobody discussing IGF-1 seems to mention. This is also animal data, not human data. But it suggests that optimizing mitochondrial health may need to come before any strategy aimed at modulating IGF-1 signaling.

What the Research Actually Shows in Humans

The human evidence on IGF-1 and longevity is genuinely mixed, and any source telling you otherwise is oversimplifying.

On the protective side: a 2026 study in BMC Geriatrics (PMID: 42304246) measured plasma IGF-1 levels in 642 older adults alongside detailed wearable-sensor gait analysis. Higher IGF-1 was associated with better gait vigor, symmetry, and stability. Since walking speed is one of the most reliable longevity predictors we have, this is meaningful data, though correlation, not causation.

On the cancer risk side: large cohort studies, including analyses from the UK Biobank, have consistently linked IGF-1 levels in the upper quartile with elevated risk of several cancers, particularly in people who are also overweight or sedentary. The absolute risk increase is modest, but it’s real.

The most honest summary of the human evidence as of 2026: extremely low IGF-1 predicts frailty, falls, cognitive decline, and early death. Extremely high IGF-1 may promote cancer. Moderate IGF-1, maintained through diet, sleep, and exercise rather than pharmacological intervention, appears to be where most healthy older adults cluster. The National Institute on Aging currently does not recommend IGF-1 optimization as a formal anti-aging strategy, though it acknowledges the science as an active area of investigation.

What About Growth Hormone Therapy?

A 2026 review in Growth Hormone and IGF Research (PMID: 42308660) examined decades of somatopause treatment data and reached a frank conclusion: GH replacement therapy for age-related IGF-1 decline produces only minor improvements and carries significant side effects, including fluid retention, insulin resistance, and joint pain. It is not a strategy supported by current longevity evidence for otherwise healthy adults. The review authors describe it as a “perennial question” that keeps getting asked and keeps getting the same disappointing answer.

How to Optimize IGF-1 Naturally

You can meaningfully influence your IGF-1 levels through lifestyle. None of these require a prescription, and all of them have independent benefits beyond IGF-1 alone.

Exercise (the most reliable lever)

Resistance training and high-intensity interval training both acutely raise IGF-1 and improve tissue sensitivity to it. The effect is dose-dependent and reproducible in older adults. Regular resistance training — enough to meaningfully challenge your muscles each week — combined with adequate protein, is the single best lifestyle strategy for maintaining age-appropriate IGF-1 levels. Our complete guide to strength training for longevity covers exactly how to structure this.

Protein intake

IGF-1 is protein-sensitive. Severe caloric restriction or very low protein intake suppresses IGF-1, which is one reason extreme fasting regimens can be counterproductive for muscle maintenance in older adults. How much protein you need to support IGF-1 without excess depends on your bodyweight, training volume, kidney function, and age — a target your clinician can help you land on once they can see your labs and history. How much protein you actually need after 60 goes deeper on this.

Sleep quality

Growth hormone, the upstream driver of IGF-1 production, is released almost entirely during slow-wave sleep. Poor or fragmented sleep directly suppresses GH pulses and, over time, lowers IGF-1. Protecting 7 to 8 hours of quality sleep isn’t optional if you want to maintain healthy IGF-1 levels.

Fasting and caloric restriction

Reducing caloric intake significantly lowers IGF-1. In animal models, this is part of how caloric restriction extends lifespan. In humans, the picture is more complicated: too much IGF-1 suppression through aggressive fasting may accelerate muscle loss in people already at risk of sarcopenia. Moderate time-restricted eating is unlikely to drive IGF-1 to problematic lows in otherwise healthy adults who eat adequate protein.

Affiliate Disclosure: The Longevity Dose may earn a small commission if you purchase through the links below, at no additional cost to you. We only recommend products we genuinely believe in. Learn more.

Common Misconceptions About IGF-1

Misconception 1: Higher IGF-1 always means better health

This is the growth hormone clinic sales pitch, and it’s not supported by the evidence. High-normal to elevated IGF-1 in healthy, well-nourished adults correlates with cancer risk in large epidemiological studies. The goal is adequate IGF-1 for tissue maintenance and neurological function, not maximized IGF-1 for performance.

Misconception 2: Centenarians have low IGF-1, so you should too

Some centenarian populations, particularly those with Laron syndrome or certain genetic variants, do show reduced IGF-1 signaling and appear to live long lives. But this is genetic, lifelong, and accompanied by dwarfism and other metabolic adaptations. Deliberately suppressing IGF-1 in a healthy 50-year-old through extreme caloric restriction is not the same thing, and the tradeoffs (muscle loss, bone density, immune function) are significant.

Misconception 3: You can’t do anything about age-related IGF-1 decline

This is too pessimistic. Resistance exercise, adequate protein intake, and good sleep hygiene are all well-documented drivers of age-appropriate IGF-1 maintenance. The decline is real but not entirely fixed. Lifestyle accounts for a substantial portion of the variance in IGF-1 levels among people of the same age.

Misconception 4: IGF-1 and insulin resistance are the same problem

IGF-1 and insulin share structural similarities and overlap in some signaling pathways. But they’re distinct. You can have low IGF-1 and significant insulin resistance simultaneously, which is a particularly bad combination for metabolic and muscle health. If you’re tracking metabolic biomarkers, you need both. They don’t substitute for each other.

How to Actually Get Your IGF-1 Tested

IGF-1 testing is a standard blood test, not exotic. Most functional medicine physicians and longevity-focused clinicians order it routinely. In the US, you can also order it directly through services like Ulta Lab Tests or LabCorp without a physician order in most states.

The test measures serum IGF-1 in nanograms per milliliter (ng/mL). Reference ranges vary by age, sex, and lab, but what range to aim for depends on your age, sex, cancer risk history, and the lab running the test — a question your ordering physician is better placed to answer than any general figure a publication can offer are low. Dr. Peter Attia, whose framework on IGF-1 and the mTOR tradeoff is outlined in Outlive, recommends tracking IGF-1 alongside fasting insulin, ApoB, and other metabolic markers as part of a comprehensive panel.

IGF-1 should not be tested in isolation. Pairing it with the full longevity biomarker panel gives you meaningful context rather than a single number to chase.

Frequently Asked Questions

What is a normal IGF-1 level for a 50-year-old?

Reference ranges vary by laboratory, but reference ranges vary meaningfully by laboratory, age, and sex, which is why your result should be read against the range your specific lab provides for your demographic. What counts as favorable depends on your lab’s age- and sex-specific reference range, your cancer risk profile, and your full metabolic picture — exactly the conversation to have with the physician reviewing your results. Always interpret your result alongside the lab’s age-specific reference range and in consultation with a physician familiar with your full medical history.

Does IGF-1 drop when you fast?

Yes. IGF-1 is sensitive to both caloric restriction and protein intake. Fasting lowers IGF-1, and the working hypothesis in the research literature is that this temporary suppression contributes to how fasting activates autophagy and cellular repair pathways — though the causal chain in humans is not yet fully established. However, chronic aggressive caloric restriction that drives IGF-1 persistently low is associated with muscle loss and immune dysfunction in humans, particularly in adults over 50.

Can you raise IGF-1 without growth hormone injections?

Yes, and that’s the preferred approach for most healthy adults. Resistance training, consistent adequate protein intake distributed across meals, and protecting slow-wave sleep are the three well-documented levers for maintaining age-appropriate IGF-1 naturally. These interventions also carry independent benefits for muscle, brain, and metabolic health that exogenous GH does not replicate and cannot replace.

Is low IGF-1 linked to dementia or cognitive decline?

The association is real, though not proven causal in humans. A 2026 review in Metabolic Brain Disease (PMID 41779215) documented that IGF-1 decline is associated with neurodegeneration in Parkinson’s disease, with IGF-1 appearing to protect dopaminergic neurons through anti-inflammatory mechanisms. Broader observational data links low IGF-1 to poorer cognitive performance in older adults. Whether increasing IGF-1 protects cognition in people without deficiency is unknown and not established in human trials.

Should I take any supplements to support IGF-1?

No supplement directly and reliably raises IGF-1 to a meaningful degree in healthy adults. Some evidence suggests zinc and magnesium deficiency may blunt GH signaling, so correcting deficiencies is reasonable. Beyond that, the evidence does not support any specific supplement for IGF-1 optimization. The lifestyle interventions (resistance training, protein, sleep) are far better supported than any pill on the market as of 2026.